Life Science REIT plc (LON:LABS)

London flag London · Delayed Price · Currency is GBP · Price in GBX
43.10
0.00 (0.00%)
Inactive · Last trade price on Apr 17, 2026
Market Cap150.85M -1.1%
Revenue (ttm)21.04M +4.6%
Net Income-30.67M
EPS-0.09
Shares Out350.00M
PE Ration/a
Forward PE35.92
Dividendn/a
Ex-Dividend Daten/a
Volume1,837,647
Average Volume719,573
Open43.00
Previous Closen/a
Day's Range41.50 - 43.10
52-Week Range34.00 - 49.00
Beta0.07
RSI61.31
Earnings DateApr 2, 2026

About Life Science REIT

Life Science REIT plc is a specialist property business focused on the UK's growing life science sector. The Company's portfolio of assets is located across the Golden Triangle of research and development hubs in Oxford, Cambridge and London's Knowledge Quarter. Life Science REIT trades on the Main Market of the London Stock Exchange under the ticker LABS. Life Science REIT plc was incorporated in July 27th 2021. [Read more]

Founded 2021
Country United Kingdom
Stock Exchange London Stock Exchange
Ticker Symbol LABS
Full Company Profile

Financial Performance

In 2024, Life Science REIT's revenue was 20.31 million, an increase of 1.84% compared to the previous year's 19.94 million. Losses were -13.98 million, -35.61% less than in 2023.

Financial Statements

News

Life Science REIT Earnings Call Transcript: H1 2024

Leasing momentum and rental growth are accelerating, with robust ERV growth and increased occupancy. Portfolio value remains stable despite yield shifts, and the business is well-financed with fully hedged debt and ample liquidity for development.

1 year ago - Transcripts